Back to Results
First PageMeta Content
Financial economics / Shareholder rights plan / Bill Ackman / Martin Lipton / Allergan / Wachtell /  Lipton /  Rosen & Katz / Takeover / Corporate raid / Corporate law / Mergers and acquisitions / Business / Investment


Did Bill Ackman just kill the poison pill? Fortune By Stephen Gandel November 6, 2014 The Valeant-Allergan fight shows that hedge fund activists are getting better at swallowing
Add to Reading List

Document Date: 2014-11-07 11:52:31


Open Document

File Size: 87,07 KB

Share Result on Facebook
UPDATE